We examine current methylphenidate dosing and unpack what the research tells us about prescribing beyond conventional limits when clinically indicated for children and adolescents.

There are so many alleged herbal remedies touted to treat psychiatric disorders. See our take on this head to head study of Crocus Sativus aka. Saffron versus methylphenidate in ADHD.

From the Oval Office to the college dorm, stimulants are often used as performance-enhancing drugs. The ethics of this practice are questionable, but so is the science. New research suggests their pro-cognitive effects are mild at best and come with an unexpected cost on working memory.

In this article we discuss a newly FDA-approved formulation for ADHD. Adhansia XR, is a new formulation of extended-release methylphenidate approved by the FDA for the treatment of ADHD in patients 6 years and older.

In the article we discuss the effectiveness and safety of the first non-drug treatment for ADHD in kids. The FDA has recently granted medical device approval for its external Monarch Trigeminal Nerve Stimulation (eTNS) System for treating kids with ADHD ages 7–12 who are not currently taking medications.